newsmaker

Unleash Your Leadership Potential: Tracy Spears and Wally Schmader Release Third Edition of Popular Guide

Know What Exceptional Leaders Know in 2023 Leadership Development Experts Tracy Spears and Wally Schmader Release Third Edition of Popular Leadership Guide TULSA, Okla., Dec. 22, 2022 (GLOBE NEWSWIRE) — The world’s workplace vitality depends on new skills, strategies, and ideas for middle management and C-suite teams. Perhaps no one understands these complexities more than…

Read More

Get Ready to Slip and Slide: Lubricant Packaging Market Projected to Reach USD 7.37 Billion by 2028 with a 6.85% CAGR – According to Market Research Future (MRFR)

Insights into the Lubricant Packaging Market Market Overview The Lubricant Packaging Market is expected to witness significant growth in the coming years, with a projected worth of USD 7.37 billion by 2028. The market is poised to grow at a compound annual growth rate (CAGR) of 6.85%, driven by various factors such as the increasing…

Read More

Journey Medical Corporation Reveals Promising Comparative Pharmacokinetic (PK) Data for DFD-29: A Step Towards Improved Medical Treatment

Journey Medical Corporation Announces Positive Comparative Phar… Phase 3 Registrational Studies Progressing Smoothly SCOTTSDALE, Ariz., Dec. 20, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”), a commercial-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced positive PK comparability data. Exciting news…

Read More

Unlocking the Future: Bioasis Technologies Inc. Hosts Exclusive Shareholder Webinar!

Bioasis Technologies Inc. Announces Shareholder Webinar NEW HAVEN, Conn., Dec. 14, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI) (OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and a differentiated, proprietary xB3 ™ platform for delivering therapeutics across the blood-brain barrier…

Read More

Revolutionizing Cardiac Procedures: BioSig’s Pure EP System Showcases Time and Cost Efficiency at the 15th APHRS Scientific Session in Singapore

PURE EP™ Study Shows Promising Results at Asia-Pacific Heart Rhythm Society Conference Westport, CT, Dec. 14, 2022 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, recently presented exciting findings at the premier…

Read More